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Differential for diffuse alveolar calcific disease:
• Metastatic pulmonary calcification (i.e., calcium salt 
deposition in normal tissues as a function of systemic 
illness including end-stage renal disease)
• Dystrophic pulmonary calcification (i.e., calcification 
occurring in tissue damaged by infectious and non-
infectious diseases including tuberculosis and sarcoid)
• Pulmonary alveolar microlithiasis (a genetic calcific 
disorder)
Pathophysiology of pulmonary alveolar microlithiasis: 
• Rare genetic mutation of the SLC34A2 gene
• Abnormal type IIb sodium phosphate cotransporter in 
alveolar type II cells
• Dysfunctional cotransporter fails to clear phosphate 
from degraded surfactant
• Results in microlith accumulation, chronic 
inflammation, tissue destruction, pulmonary fibrosis, 
and respiratory failure. 2,3
Characteristics and natural history: 
• Most common in Asia
• Identified in 65 countries, but with highest prevalence 
in Turkey, Japan, and Italy
• Most patients are under 50y and approximately 35% 
present under the age of 20y
• Patients present with dyspnea (24%), nonproductive 
cough (14%), and chest pain (6%); severity ranges from 
asymptomatic to respiratory failure
• Diagnosis typically made with CT chest + bronchoscopy 
with bronchoalveolar lavage demonstrating intra-
alveolar lamellar microliths
• Most progress to respiratory failure and cor pulmonale
• No established therapy for PAM; only definitive 
treatment is lung transplantation
The inpatient team and pulmonologist attributed  
presentation to progression of underlying chronic illness 
rather than a new or superimposed insult.
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INTRODUCTION
• Widespread pulmonary calcification is an 
uncommon finding in patients with dyspnea
• Pulmonary alveolar microlithiasis (PAM) is an 
extremely rare genetic disease
• Deposition of calcium phosphate microliths 
chokes the alveoli and small airways
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33yo Arab-Berber female from the Mediterranean 
presented to ER with acute on chronic dyspnea
• 10-year history of exertional dyspnea 
• 2 days of acute, exertional and resting dyspnea 
• Associated fever, pleurisy, and anxiety
Physical exam: 
• 68% O2 sat on room air à 92% on 2L O2
• Tachypnea without accessory muscle usage
• Diffuse bronchial breath sounds
• Clubbing of digits
Initial diagnostics:
• Polycythemia, Hemoglobin 16.7
• Positive QuantiFERON gold test
• CXR: dense bilateral multilobar alveolar infiltrates; 
often described as “sandstorm” appearance
• CT Chest: Sub-total opacification of the lung 
parenchyma with calcific densities and 
superimposed air bronchograms
Inpatient evaluation: 
• Bronchoscopy with bronchoalveolar lavage: 
scattered calcified concretions
• Negative blood and sputum cultures
• Negative fungal cultures
• Negative atypical respiratory panel
• Negative autoimmune workup
Disposition: 
• Discussed lung transplant candidacy; patient 
refused work-up
• Discharged with supplemental oxygen
• Completed latent tuberculosis treatment
• Scheduled with interstitial lung disease specialist 
• Lost to follow up after leaving United States
LEARNING OBJECTIVES
Figure 1: Diffuse “Sandstorm” lung appearance on Initial Chest X-Ray Figure 2:  High Resolution Chest CT Coronal View 
Figure 5: Low power at 25x magnification Figure 6: Medium  power 100x magnification   
CONCLUSION
Figure 5: High power at 200x magnification 
BRONCHOSCOPY + BRONCHOALVEOLAR LAVAGE PATHOLOGY SLIDES
Figure 3: High Resolution Chest CT Axial View Figure 5: High Resolution Chest CT Sagittal View 
• Develop differential diagnosis for radiographic 
appearance of diffuse pulmonary calcification
• Explain the pathophysiology of pulmonary alveolar 
microlithiasis (PAM)
• Describe presenting characteristics, natural history, 
and treatment of PAM
Calcified concentrations (large purple cells), pulmonary macrophages are the background cells  (round, polygonal with a lot of cytoplasm) and a few bronchial epithelial cells 
